← Surgery Partners, Inc. SGRY
Market Price
$15.01
Market Cap
$1.99B
P/E Ratio
N/A
Revenue (FY 2025)
↑6.2% YoY
$3.31B
3-Yr CAGR: 9.2%
Net Income
↑53.7% YoY
-$77.90M
Net Margin: -2.4%
Free Cash Flow
↓-6.7% YoY
$195.60M
FCF Yield: 9.85%
EPS (Diluted)
↑54.1% YoY
$-0.61
Basic: $-0.61
Return on Equity
Efficiency
-4.5%
ROA: -1.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (SGRY)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2015 | $959.9M | — | $290.6M | $1.4M | — | $0.04 | — | $84.5M | $51.0M | — |
| FY 2016 | $1,145.4M | +19.3% | $324.2M | $9.5M | +561.5% | $0.20 | +400.0% | $125.2M | $86.1M | +68.7% |
| FY 2017 | — | — | — | — | — | — | — | — | — | — |
| FY 2018 | $1,771.5M | — | $410.0M | $-205.7M | — | $-4.96 | — | $144.6M | $104.8M | — |
| FY 2019 | $1,831.4M | +3.4% | $423.8M | $-74.8M | +63.6% | $-2.29 | +53.8% | $129.5M | $55.9M | -46.7% |
| FY 2020 | $1,860.1M | +1.6% | $379.8M | $-116.1M | -55.2% | $-3.19 | -39.3% | $246.9M | $204.0M | +264.9% |
| FY 2021 | $2,225.1M | +19.6% | $491.4M | $-70.9M | +38.9% | $-1.12 | +64.9% | $87.1M | $29.5M | -85.5% |
| FY 2022 | $2,539.3M | +14.1% | $574.9M | $-54.6M | +23.0% | $-0.59 | +47.3% | $158.8M | $78.2M | +165.1% |
| FY 2023 | $2,743.3M | +8.0% | $647.5M | $-11.9M | +78.2% | $-0.09 | +84.7% | $293.8M | $205.0M | +162.1% |
| FY 2024 | $3,114.3M | +13.5% | $745.6M | $-168.1M | -1,312.6% | $-1.33 | -1,377.8% | $300.1M | $209.7M | +2.3% |
| FY 2025 | $3,308.7M | +6.2% | $765.0M | $-77.9M | +53.7% | $-0.61 | +54.1% | $274.3M | $195.6M | -6.7% |
Valuation
Market Price
$15.01
Market Cap
$1.99B
Enterprise Value
$2.27B
P/E Ratio
N/A
P/B Ratio
1.15
FCF Yield
9.85%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
23.12%
Operating Margin
11.77%
Net Margin
-2.35%
Return on Equity (ROE)
-4.55%
Return on Assets (ROA)
-0.96%
Asset Turnover
0.41x
Revenue 3-Yr CAGR
9.22%
Financial Health & Liquidity
Current Ratio
1.87
Cash Ratio
0.39
Debt / Equity
0.304
Debt / Assets
0.064
Cash & Equivalents
$239.90M
Total Debt
$521.20M
Book Value / Share
$13.10
Cash Flow Efficiency
Operating Cash Flow
$274.30M
Capital Expenditures (CapEx)
$78.70M
Free Cash Flow
$195.60M
OCF / Revenue
8.29%
FCF / Revenue
5.91%
FCF 3-Yr CAGR
35.74%
Per Share Metrics
EPS (Diluted)
$-0.61
EPS (Basic)
$-0.61
Dividends / Share
N/A
Book Value / Share
$13.10
EPS YoY Growth
54.14%
Balance Sheet (FY 2025)
Total Assets
$8.12B
Total Liabilities
$8.12B
Stockholders' Equity
$1.71B
Current Assets
$1.15B
Current Liabilities
$615.50M